pharnext

Showing 2 posts of 2 posts found.

Pharnext CMT drug shows positive Phase III results

April 29, 2021
CMT, Charcot-Marie-Tooth Disease, Phase III trial, pharma, pharma news, pharnext

Pharnext SA’s PXT3003 treatment for patients with Charcot-Marie-Tooth Disease (CMT) has shown positive interim results in its ongoing Phase III …

michel-de-rosen

Pharnext adds industry veteran to board

December 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michel de Rosen, pharnext

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …

The Gateway to Local Adoption Series

Latest content